NFκB has been commonly seen in cell lines and tumor samples, and leads to drug resistance and malignancy in most forms of human cancer such as lymphoma, breast, prostate, lung, colon, pancreas, head and neck (9). This evidence concerns the gene NFKB1 and cancer.